Sonoma Pharmaceuticals (SNOA) Tops Q1 EPS by 21c
Tweet
Share
E-mailGet Alerts SNOA Hot Sheet
Join SI Premium – FREE
Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q1 EPS of ($0.09), $0.21 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $4.99 million.
For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cencora says Walgreens volumes shift, reaffirms guidance, shares sink
- CFRA Downgrades 3M (MMM) to Buy
- Goldman Sachs expects July core PCE to rise 0.23%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
